Search

Your search keyword '"Tiziana Crepaldi"' showing total 92 results

Search Constraints

Start Over You searched for: Author "Tiziana Crepaldi" Remove constraint Author: "Tiziana Crepaldi" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
92 results on '"Tiziana Crepaldi"'

Search Results

1. The MET Oncogene: Thirty Years of Insights into Molecular Mechanisms Driving Malignancy

2. MET Oncogene Enhances Pro-Migratory Functions by Counteracting NMDAR2B Cleavage

3. Identification of novel circulating microRNAs in advanced heart failure by next‐generation sequencing

4. NMDA Receptor and Its Emerging Role in Cancer

5. Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor

6. The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor

7. HGF and MET: From Brain Development to Neurological Disorders

8. Two-Chains Tissue Plasminogen Activator Unifies Met and NMDA Receptor Signalling to Control Neuronal Survival

9. The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3

10. Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes

11. HGF/Met Axis in Heart Function and Cardioprotection

12. ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy

13. Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes

14. Activated Met signalling in the developing mouse heart leads to cardiac disease.

15. Data from Validation of Met as a Therapeutic Target in Alveolar and Embryonal Rhabdomyosarcoma

18. MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor

19. Factor XII protects neurons from apoptosis by epidermal and hepatocyte growth factor receptor-dependent mechanisms

20. Coagulation Factor XII protects neurons from apoptosis by triggering a crosstalk between HGFR/c-Met and EGFR/ErbB1 signaling pathways

21. The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3

22. Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody

23. ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy

24. Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes

25. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

26. HGF-mimic antibody administration to counteract doxorubicin cardiotoxicity

27. MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine

28. Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes

29. Author response: Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes

30. Erratum

31. A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart

32. Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib

33. Cytolitic Activity of Monoclonal Antibodies Strongly Depends on Rabbit Complement Used

34. Further antigenic determinants on HLA-A molecules

35. Characterization by monoclonal antibodies of lymphocyte subsets present in B-enriched suspensions

36. An In vivo Model of Met-Driven Lymphoma as a Tool to Explore the Therapeutic Potential of Met Inhibitors

37. Bortezomib-mediated proteasome inhibition as a potential strategy for the treatment of rhabdomyosarcoma

38. Conditional Activation of MET in Differentiated Skeletal Muscle Induces Atrophy

39. Cellular and molecular mechanisms of HGF/Met in the cardiovascular system

40. Met activation for cardioprotection against anthracycline cardiotoxicity

41. RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis

42. HGF/Met Axis in Heart Function and Cardioprotection

43. HGF/Met axis has anti-apoptotic and anti-autophagic function in hypoxic cardiac injury

44. Effect of hepatocyte growth factor on assembly of zonula occludens-1 protein at the plasma membrane

45. Ezrin Is an Effector of Hepatocyte Growth Factor–mediated Migration and Morphogenesis in Epithelial Cells

46. Gene expression profiling of HGF/Met activation in neonatal mouse heart

48. Digoxin and ouabain induce the efflux of cholesterol via liver X receptor signalling and the synthesis of ATP in cardiomyocytes

49. Mek1 inhibition in vivo mitigates progressive cardiac concentric hypertrophy promoted by activated Met receptor

50. Signaling to cardiac hypertrophy: insights from human and mouse RASopathies

Catalog

Books, media, physical & digital resources